CA2326517A1 — New galenic preparations of meloxicam for oral administration
Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 1999-10-07 · 27y expired
What this patent protects
The invention relates to the use of a meloxicam salt of an inorganic or organic base for preparing an orally administered, solid pharmaceutical preparation from which the active substance is rapidly released and absorbed, for pain therapy, corresponding pharmaceutical preparation…
USPTO Abstract
The invention relates to the use of a meloxicam salt of an inorganic or organic base for preparing an orally administered, solid pharmaceutical preparation from which the active substance is rapidly released and absorbed, for pain therapy, corresponding pharmaceutical preparations made by direct tabletting and the process for preparing them.
Drugs covered by this patent
- Mobic (MELOXICAM) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.